TrialAntimicrobial agents and chemotherapy2015

In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122.

Søren Ottosen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.